Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alpha Borocarbonyl Compounds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110590821B details a safe iridium-catalyzed method using sulfur ylides for alpha-borocarbonyls, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110590821A details mild iridium-catalyzed synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with stable raw materials and high purity.